SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-138840
Filing Date
2018-04-27
Accepted
2018-04-27 16:06:58
Documents
4
Period of Report
2018-06-19
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d508087ddef14a.htm DEF 14A 446622
2 GRAPHIC g508087g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g508087g99y44.jpg GRAPHIC 30556
4 GRAPHIC g508087pc02.jpg GRAPHIC 7568
  Complete submission text file 0001193125-18-138840.txt   519752
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 18783884
SIC: 2834 Pharmaceutical Preparations